Dietary supplement considerations during GLP-1 treatment: A narrative review

Review Highlights Nutritional Strategies to Support Health During GLP-1 Treatment

This narrative review examines nutritional considerations during treatment with GLP-1 receptor agonists (GLP-1RAs), medications increasingly used for obesity and weight management. Researchers note that while these therapies can lead to significant weight loss, nutritional guidance for patients is still evolving.

The review found that targeted dietary supplements may help support health during GLP-1RA treatment. Multivitamins may help address nutrient gaps. Protein supplements may help preserve lean muscle mass during weight loss. Fiber and probiotics may support digestive health and improve bowel regularity.

Researchers also highlighted potential benefits from creatine, β-Hydroxy β-Methylbutyrate (HMB), and antioxidant and anti-inflammatory nutrients. Key takeaways include the importance of adequate protein intake, resistance training, muscle preservation, and digestive support. The authors concluded that combining strategic nutrition support with GLP-1RA therapy may help improve long-term health outcomes during obesity treatment.

Related Resources

Learn more about dietary fiber.

Read the study.

Explore More

Scientists, regulatory authorities and professional health organizations have extensively ‎evaluated Ace-K. See their statements.
European Food Safety Authority reaffirms safety of aspartame, ace-k and aspartame–acesulfame salt, citing is no safety concern at the reported uses and use levels.
A conference presentation on unpublished science should not outweigh decades of scientific evidence. CCC responds to a recent study on xylitol.
A landmark study examined how beverages sweetened with sugar or low/no calorie sweeteners affect the brain, blood sugar, insulin, digestion, & appetite.
One of the largest investigations of beverage consumption and liver cancer risk finds no link between low/no calorie sweetened beverages and liver cancer.
A global overview of regulatory approvals for low- and no-calorie sweeteners, including a country-by-country comparison of ingredient permissions.